Filter
3195
Filtered Results: 3195
Text search:
drug
distribution
guidelines
Featured
Recommendations
278
New Publications
965
Language
Document type
No document type
2077
Studies & Reports
414
Guidelines
411
Manuals
119
Strategic & Response Plan
102
Training Material
32
Fact sheets
25
Situation Updates
12
Infographics
2
Resource Platforms
1
Countries / Regions
India
169
Kenya
117
Uganda
94
Ethiopia
88
Nigeria
86
Global
78
South Africa
75
Sierra Leone
64
Liberia
64
Nepal
63
Malawi
62
Tanzania
60
Western and Central Europe
58
Ghana
53
Zambia
53
Myanmar / Burma
46
Rwanda
45
Latin America and the Carribbean
45
Bangladesh
42
Namibia
38
Ukraine
35
Africa
35
Philippines
31
Eastern Europe
31
Zimbabwe
29
Cambodia
28
Lesotho
26
Asia
21
Botswana
21
South–East Asia Region
20
Russia
18
Senegal
17
Mozambique
16
Indonesia
15
Colombia
14
Congo, Democratic Republic of
13
East and Southern Africa
13
Burkina Faso
12
Brazil
12
Syria
11
Thailand
10
USA
10
Haiti
9
Eswatini/ Swaziland
9
Albania
8
West and Central Africa
8
Middle East and North Africa
8
Paraguay
8
Cameroon
7
Germany
7
Eastern Europe and Central Asia
7
Argentina
7
Pakistan
7
Benin
6
Guinea
6
Georgia
6
Tajikistan
5
Laos
5
Peru
5
Venezuela
5
Vietnam
5
Sudan
5
South Sudan
5
Iraq
5
Spain
4
Sri Lanka
4
North Macedonia
3
Timor Leste/ East Timor
3
Afghanistan
3
Armenia
3
Western Pacific Region
3
Bolivia
3
Lebanon
3
Bhutan
3
Mexico
2
El Salvador
2
Turkey
2
Chile
2
Iran
2
Fiji
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Jordan
2
United Kingdom
2
Portugal
2
Moldova
2
Central African Republic
2
Honduras
2
Angola
2
North Korea
1
Kazakhstan
1
Canada
1
Estonia
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Yemen
1
Romania
1
Greece
1
Palestine
1
Somalia
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1393
Clinical Guidelines
296
Public Health
170
Women & Child Health
121
Key Resources
63
Pharmacy & Technologies
52
Capacity Building
46
Annual Report MEDBOX
1
Toolboxes
HIV
371
TB
274
Mental Health
250
AMR
169
Pharmacy
119
COVID-19
116
NTDs
104
Rapid Response
62
Caregiver
55
NCDs
50
Planetary Health
37
Refugee
33
Disability
33
Ebola
30
Conflict
30
Global Health Education
21
Natural Hazards
13
Polio
13
Cholera
10
Zika
10
Specific Hazards
9
Health Financing Toolbox
7
Social Ethics
3
Health Financing
1
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Since the Alma Ata Declaration in 1978, community health volunteers (CHVs) have been at the forefront, providing health services, especially to underserved communities, in low-income countries. However, consolidation of CHVs position within formal health systems has proved to be complex and continue...
The Government of Malawi is committed to improving health and livelihoods in Malawi through community health – the
provision of basic health services in rural and urban communities with the participation of people who live there.
Historically, Community Health has significantly contributed to im...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an implementation plan.
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularly during the COVID-19 pandemic. It highlights regio...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium ...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris...
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds upon the work of the International Study of Asthma and Allergies in Childhood (ISAAC) and The International Union Against Tuberculosis and Lung Disease (T...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
